Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 1223

1.

Long non-coding RNA SNHG7 promotes migration and invasion of melanoma via upregulating SOX4.

Zhang C, Zhu B, Li XB, Cao YQ, Yang JC, Li X, Liu YX, Wang YB.

Eur Rev Med Pharmacol Sci. 2019 Jun;23(11):4828-4834. doi: 10.26355/eurrev_201906_18069.

PMID:
31210315
2.

[Quality assessment of global guidelines on colorectal cancer screening].

Gao L, Yu SQ, Yang JC, Ma JL, Zhan SY, Sun F.

Beijing Da Xue Xue Bao Yi Xue Ban. 2019 Jun 18;51(3):548-555. doi: 10.19723/j.issn.1671-167X.2019.03.026. Chinese.

PMID:
31209430
3.

Anomalous phonon relaxation in Au333(SR)79 nanoparticles with nascent plasmons.

Higaki T, Zhou M, He G, House SD, Sfeir MY, Yang JC, Jin R.

Proc Natl Acad Sci U S A. 2019 Jun 17. pii: 201904337. doi: 10.1073/pnas.1904337116. [Epub ahead of print]

PMID:
31209027
4.

Afatinib is effective in the treatment of lung adenocarcinoma with uncommon EGFR p.L747P and p.L747S mutations.

Liang SK, Ko JC, Yang JC, Shih JY.

Lung Cancer. 2019 Jul;133:103-109. doi: 10.1016/j.lungcan.2019.05.019. Epub 2019 May 17.

PMID:
31200815
5.

First-line afatinib for advanced EGFRm+ NSCLC: Analysis of long-term responders in the LUX-Lung 3, 6, and 7 trials.

Schuler M, Paz-Ares L, Sequist LV, Hirsh V, Lee KH, Wu YL, Lu S, Zhou C, Feng J, Ellis SH, Samuelsen CH, Tang W, Märten A, Ehrnrooth E, Park K, Yang JC.

Lung Cancer. 2019 Jul;133:10-19. doi: 10.1016/j.lungcan.2019.04.006. Epub 2019 Apr 8.

PMID:
31200814
6.

Predifferentiated amniotic fluid mesenchymal stem cells enhance lung alveolar epithelium regeneration and reverse elastase-induced pulmonary emphysema.

Lan YW, Yang JC, Yen CC, Huang TT, Chen YC, Chen HL, Chong KY, Chen CM.

Stem Cell Res Ther. 2019 Jun 13;10(1):163. doi: 10.1186/s13287-019-1282-1.

7.

Highly Uniform and Low Hysteresis Piezoresistive Pressure Sensors Based on Chemical Grafting of Polypyrrole on Elastomer Template with Uniform Pore Size.

Oh J, Kim JO, Kim Y, Choi HB, Yang JC, Lee S, Pyatykh M, Kim J, Sim JY, Park S.

Small. 2019 Jun 13:e1901744. doi: 10.1002/smll.201901744. [Epub ahead of print]

PMID:
31192540
8.

Cranial Irradiation for Patients with Epidermal Growth Factor Receptor (EGFR) Mutant Lung Cancer Who Have Brain Metastases in the Era of a New Generation of EGFR Inhibitors.

Lee JH, Chen HY, Hsu FM, Chen JS, Liao WY, Shih JY, Yu CJ, Chen KY, Tsai TH, Yang JC.

Oncologist. 2019 May 24. pii: theoncologist.2019-0152. doi: 10.1634/theoncologist.2019-0152. [Epub ahead of print]

PMID:
31127020
9.

Sequencing of therapy following first-line afatinib in patients with EGFR mutation-positive non-small cell lung cancer.

Park K, Bennouna J, Boyer M, Hida T, Hirsh V, Kato T, Lu S, Mok T, Nakagawa K, O'Byrne K, Paz-Ares L, Schuler M, Sibilot DM, Tan EH, Tanaka H, Wu YL, Yang JC, Zhang L, Zhou C, Märten A, Tang W, Yamamoto N.

Lung Cancer. 2019 Jun;132:126-131. doi: 10.1016/j.lungcan.2019.04.014. Epub 2019 Apr 10.

10.

Adoptive T-Cell Therapy for Solid Malignancies.

Jafferji MS, Yang JC.

Surg Oncol Clin N Am. 2019 Jul;28(3):465-479. doi: 10.1016/j.soc.2019.02.012. Epub 2019 Apr 12. Review.

PMID:
31079800
11.

Deterministic optical control of room temperature multiferroicity in BiFeO3 thin films.

Liou YD, Chiu YY, Hart RT, Kuo CY, Huang YL, Wu YC, Chopdekar RV, Liu HJ, Tanaka A, Chen CT, Chang CF, Tjeng LH, Cao Y, Nagarajan V, Chu YH, Chen YC, Yang JC.

Nat Mater. 2019 Jun;18(6):580-587. doi: 10.1038/s41563-019-0348-x. Epub 2019 May 6.

PMID:
31061484
12.

Microstructured Porous Pyramid-Based Ultrahigh Sensitive Pressure Sensor Insensitive to Strain and Temperature.

Yang JC, Kim JO, Oh J, Kwon SY, Sim JY, Kim DW, Choi HB, Park S.

ACS Appl Mater Interfaces. 2019 May 29;11(21):19472-19480. doi: 10.1021/acsami.9b03261. Epub 2019 May 14.

PMID:
31056895
13.

Good hemostatic effect of platelets stored at 4°C in an in vitro model of massive blood loss and thrombocytopenia.

Yang JC, Liu FH, Sun Y, Ma T, Xu CX, Wang WH, Chen P, Xie XX, Song YJ, Yin W.

Medicine (Baltimore). 2019 May;98(18):e15454. doi: 10.1097/MD.0000000000015454.

14.

Metformin inhibits the proliferation of rheumatoid arthritis fibroblast-like synoviocytes through IGF-IR/PI3K/AKT/m-TOR pathway.

Chen K, Lin ZW, He SM, Wang CQ, Yang JC, Lu Y, Xie XB, Li Q.

Biomed Pharmacother. 2019 Jul;115:108875. doi: 10.1016/j.biopha.2019.108875. Epub 2019 Apr 24.

15.

First-line afatinib for the treatment of EGFR mutation-positive non-small-cell lung cancer in the 'real-world' clinical setting.

Park K, Wan-Teck Lim D, Okamoto I, Yang JC.

Ther Adv Med Oncol. 2019 Apr 15;11:1758835919836374. doi: 10.1177/1758835919836374. eCollection 2019. Review.

16.

In Vitro and In Vivo Studies of Hydrophilic Electrospun PLA95/β-TCP Membranes for Guided Tissue Regeneration (GTR) Applications.

Chen CC, Lee SY, Teng NC, Hu HT, Huang PC, Yang JC.

Nanomaterials (Basel). 2019 Apr 11;9(4). pii: E599. doi: 10.3390/nano9040599.

17.

Bevacizumab in EGFR-positive NSCLC: time to change first-line treatment?

Yang JC.

Lancet Oncol. 2019 May;20(5):602-603. doi: 10.1016/S1470-2045(19)30085-3. Epub 2019 Apr 8. No abstract available.

PMID:
30975629
18.

Drug efficacies on bone mineral density and fracture rate for the treatment of postmenopausal osteoporosis: a network meta-analysis.

Yang L, Kang N, Yang JC, Su QJ, Liu YZ, Guan L, Liu T, Meng XL, Wang Y, Hai Y.

Eur Rev Med Pharmacol Sci. 2019 Mar;23(6):2640-2668. doi: 10.26355/eurrev_201903_17414.

19.

Receptor tyrosine kinase gene amplification is predictive of intraoperative seizures during glioma resection with functional mapping.

Choi BD, Lee DK, Yang JC, Ayinon CM, Lee CK, Maus D, Carter BS, Barker FG, Jones PS, Nahed BV, Cahill DP, See RB, Simon MV, Curry WT.

J Neurosurg. 2019 Mar 29:1-7. doi: 10.3171/2018.12.JNS182700. [Epub ahead of print]

PMID:
30925466
20.

Pilot Trial of Adoptive Transfer of Chimeric Antigen Receptor-transduced T Cells Targeting EGFRvIII in Patients With Glioblastoma.

Goff SL, Morgan RA, Yang JC, Sherry RM, Robbins PF, Restifo NP, Feldman SA, Lu YC, Lu L, Zheng Z, Xi L, Epstein M, McIntyre LS, Malekzadeh P, Raffeld M, Fine HA, Rosenberg SA.

J Immunother. 2019 May;42(4):126-135. doi: 10.1097/CJI.0000000000000260.

PMID:
30882547
21.

What happened in 133 consecutive hepatic artery reconstruction in liver transplantation in 1 year?

Lin TS, Vishnu Prasad NR, Chen CL, Yang JC, Chiang YC, Kuo PJ, Wang CC, Wang SH, Liu YW, Yong CC, Cheng YF.

Hepatobiliary Surg Nutr. 2019 Feb;8(1):10-18. doi: 10.21037/hbsn.2018.11.13.

22.

Weaning outcome of solid cancer patients requiring mechanical ventilation in the intensive care unit.

Hsiue EH, Lee PL, Chen YH, Wu TH, Cheng CF, Cheng KM, Yang PC, Chen HW, Lin PY, Chiang DL, Wu HD, Yang JC, Yu CJ.

J Formos Med Assoc. 2019 Jun;118(6):995-1004. doi: 10.1016/j.jfma.2019.02.007. Epub 2019 Mar 8.

23.

[Clinical characteristics of human adenovirus type 7 pneumonia and genetic characteristics of human adenovirus type 7].

Li XF, Xi W, Wang YY, Wang XQ, Zhao N, Wang HJ, Wu T, Yang JC, Zhang GL, Zhang LY, Zhao JL, Yang AL, Ning YY, Liu YN, Ping J, Gao ZC, Tong YG, Tian GZ.

Zhonghua Jie He He Hu Xi Za Zhi. 2019 Mar 12;42(3):206-212. doi: 10.3760/cma.j.issn.1001-0939.2019.03.011. Chinese.

PMID:
30845398
24.

A phase I study of pexidartinib, a colony-stimulating factor 1 receptor inhibitor, in Asian patients with advanced solid tumors.

Lee JH, Chen TW, Hsu CH, Yen YH, Yang JC, Cheng AL, Sasaki SI, Chiu LL, Sugihara M, Ishizuka T, Oguma T, Tajima N, Lin CC.

Invest New Drugs. 2019 Mar 2. doi: 10.1007/s10637-019-00745-z. [Epub ahead of print]

PMID:
30825104
25.

First-line afatinib vs gefitinib for patients with EGFR mutation-positive NSCLC (LUX-Lung 7): impact of afatinib dose adjustment and analysis of mode of initial progression for patients who continued treatment beyond progression.

Schuler M, Tan EH, O'Byrne K, Zhang L, Boyer M, Mok T, Hirsh V, Yang JC, Lee KH, Lu S, Shi Y, Kim SW, Laskin J, Kim DW, Arvis CD, Kölbeck K, Massey D, Märten A, Paz-Ares L, Park K.

J Cancer Res Clin Oncol. 2019 Jun;145(6):1569-1579. doi: 10.1007/s00432-019-02862-x. Epub 2019 Feb 19.

26.

Application of Data-Independent Acquisition Approach to Study the Proteome Change from Early to Later Phases of Tomato Pathogenesis Responses.

Fan KT, Wang KH, Chang WH, Yang JC, Yeh CF, Cheng KT, Hung SC, Chen YR.

Int J Mol Sci. 2019 Feb 17;20(4). pii: E863. doi: 10.3390/ijms20040863.

27.

Circ-VANGL1 promotes the progression of osteoporosis by absorbing miRNA-217 to regulate RUNX2 expression.

Yang L, Zeng Z, Kang N, Yang JC, Wei X, Hai Y.

Eur Rev Med Pharmacol Sci. 2019 Feb;23(3):949-957. doi: 10.26355/eurrev_201902_16981.

28.

[Surgical results and sagittal alignment analysis of different fusion levels for degenerative scoliosis].

Meng XL, Hai Y, Xu G, Yang JC, Su QJ.

Zhonghua Yi Xue Za Zhi. 2019 Jan 29;99(5):359-364. doi: 10.3760/cma.j.issn.0376-2491.2019.05.008. Chinese.

PMID:
30772977
29.

Phase I Study of the Focal Adhesion Kinase Inhibitor BI 853520 in Japanese and Taiwanese Patients with Advanced or Metastatic Solid Tumors.

Doi T, Yang JC, Shitara K, Naito Y, Cheng AL, Sarashina A, Pronk LC, Takeuchi Y, Lin CC.

Target Oncol. 2019 Feb;14(1):57-65. doi: 10.1007/s11523-019-00620-0.

30.

Transition-metal free C-C bond cleavage/borylation of cycloketone oxime esters.

Zhang JJ, Duan XH, Wu Y, Yang JC, Guo LN.

Chem Sci. 2018 Oct 2;10(1):161-166. doi: 10.1039/c8sc03315c. eCollection 2019 Jan 7.

31.

The Internal Validity of Discrete Choice Experiment Data: A Testing Tool for Quantitative Assessments.

Johnson FR, Yang JC, Reed SD.

Value Health. 2019 Feb;22(2):157-160. doi: 10.1016/j.jval.2018.07.876. Epub 2018 Sep 27.

PMID:
30711059
32.

Preferences of women with epithelial ovarian cancer for aspects of genetic testing.

Davidson BA, Ehrisman J, Reed SD, Yang JC, Buchanan A, Havrilesky LJ.

Gynecol Oncol Res Pract. 2019 Jan 22;6:1. doi: 10.1186/s40661-019-0066-8. eCollection 2019.

33.

Brain Activation Patterns Associated with the Effects of Fearful Distractors during Working Memory Maintenance in Patients with Schizophrenia.

Park JI, Kim GW, Jeong GW, Yang JC.

Clin Psychopharmacol Neurosci. 2019 Feb 28;17(1):54-63. doi: 10.9758/cpn.2019.17.1.54.

34.

Shape of a skyrmion.

Yang JC, Mao QQ, Shi Y.

J Phys Condens Matter. 2019 Apr 24;31(16):165802. doi: 10.1088/1361-648X/ab01ef. Epub 2019 Jan 25.

PMID:
30681977
35.

[Introduction on 'assessing the risk of bias of individual studies' in systematic review of health-care intervention programs revised by the Agency for Healthcare Research and Quality].

Yang JC, Yang ZR, Yu SQ, Zhan SY, Sun F.

Zhonghua Liu Xing Bing Xue Za Zhi. 2019 Jan 10;40(1):106-111. doi: 10.3760/cma.j.issn.0254-6450.2019.01.021. Chinese.

PMID:
30669741
36.

Phytochemical naphtho[1,2-b] furan-4,5‑dione induced topoisomerase II-mediated DNA damage response in human non-small-cell lung cancer.

Chien CM, Yang JC, Wu PH, Wu CY, Chen GY, Wu YC, Chou CK, Tseng CH, Chen YL, Wang LF, Chiu CC.

Phytomedicine. 2019 Feb 15;54:109-119. doi: 10.1016/j.phymed.2018.06.025. Epub 2018 Jun 28.

PMID:
30668360
37.

Microsurgical head and neck reconstruction in patients with coronary artery disease: A perioperative assessment algorithm.

Scaglioni MT, Giovanoli P, Scaglioni MF, Yang JC.

Microsurgery. 2019 May;39(4):290-296. doi: 10.1002/micr.30429. Epub 2019 Jan 15.

PMID:
30648284
38.

Multidisciplinary Care is the Best Approach, Anytime.

Yang JC.

Int J Radiat Oncol Biol Phys. 2019 Feb 1;103(2):296. doi: 10.1016/j.ijrobp.2018.09.045. No abstract available.

PMID:
30647005
39.

Brachytherapy Training Survey of Radiation Oncology Residents.

Marcrom SR, Kahn JM, Colbert LE, Freese CM, Doke KN, Yang JC, Yashar CM, Luu M, Kamrava M.

Int J Radiat Oncol Biol Phys. 2019 Mar 1;103(3):557-560. doi: 10.1016/j.ijrobp.2018.10.023. Epub 2018 Oct 26.

PMID:
30612963
40.

Pan-Asian adapted Clinical Practice Guidelines for the management of patients with metastatic non-small-cell lung cancer: a CSCO-ESMO initiative endorsed by JSMO, KSMO, MOS, SSO and TOS.

Wu YL, Planchard D, Lu S, Sun H, Yamamoto N, Kim DW, Tan DSW, Yang JC, Azrif M, Mitsudomi T, Park K, Soo RA, Chang JWC, Alip A, Peters S, Douillard JY.

Ann Oncol. 2019 Feb 1;30(2):171-210. doi: 10.1093/annonc/mdy554.

PMID:
30596843
41.

Highly Ordered 3D Microstructure-Based Electronic Skin Capable of Differentiating Pressure, Temperature, and Proximity.

Kim JO, Kwon SY, Kim Y, Choi HB, Yang JC, Oh J, Lee HS, Sim JY, Ryu S, Park S.

ACS Appl Mater Interfaces. 2019 Jan 9;11(1):1503-1511. doi: 10.1021/acsami.8b19214. Epub 2018 Dec 28.

PMID:
30565915
42.

Pembrolizumab in Combination With Erlotinib or Gefitinib as First-Line Therapy for Advanced NSCLC With Sensitizing EGFR Mutation.

Yang JC, Gadgeel SM, Sequist LV, Wu CL, Papadimitrakopoulou VA, Su WC, Fiore J, Saraf S, Raftopoulos H, Patnaik A.

J Thorac Oncol. 2019 Mar;14(3):553-559. doi: 10.1016/j.jtho.2018.11.028. Epub 2018 Dec 4.

PMID:
30529597
43.

[Percutaneous endoscopic transforaminal lumbar interbody fusion for lumbar spinal stenosis].

Yang JC, Hai Y, Ding Y, Yin P, Zhang YS, Liu C, Zhang LM.

Zhonghua Yi Xue Za Zhi. 2018 Dec 4;98(45):3711-3715. doi: 10.3760/cma.j.issn.0376-2491.2018.45.016. Chinese.

PMID:
30526785
44.

A Phase II Study of Tumor-infiltrating Lymphocyte Therapy for Human Papillomavirus-associated Epithelial Cancers.

Stevanović S, Helman SR, Wunderlich JR, Langhan MM, Doran SL, Kwong MLM, Somerville RPT, Klebanoff CA, Kammula US, Sherry RM, Yang JC, Rosenberg SA, Hinrichs CS.

Clin Cancer Res. 2019 Mar 1;25(5):1486-1493. doi: 10.1158/1078-0432.CCR-18-2722. Epub 2018 Dec 5.

45.

Transcriptome Analysis of Oleoresin-Producing Tree Sindora Glabra and Characterization of Sesquiterpene Synthases.

Yu N, Yang JC, Yin GT, Li RS, Zou WT.

Front Plant Sci. 2018 Nov 20;9:1619. doi: 10.3389/fpls.2018.01619. eCollection 2018.

46.

Osimertinib in patients with T790M mutation-positive, advanced non-small cell lung cancer: Long-term follow-up from a pooled analysis of 2 phase 2 studies.

Ahn MJ, Tsai CM, Shepherd FA, Bazhenova L, Sequist LV, Hida T, Yang JCH, Ramalingam SS, Mitsudomi T, Jänne PA, Mann H, Cantarini M, Goss G.

Cancer. 2019 Mar 15;125(6):892-901. doi: 10.1002/cncr.31891. Epub 2018 Dec 4.

PMID:
30512189
47.
48.
49.

Reply: Ultrasound Technology in Targeting Reflux-Free Venules for Optimal Lymphaticovenular Anastomosis in the Treatment of Lymphedema.

Yang JC.

Plast Reconstr Surg. 2018 Dec;142(6):985e. doi: 10.1097/PRS.0000000000005034. No abstract available.

PMID:
30496153
50.

Clinical outcomes and secondary epidermal growth factor receptor (EGFR) T790M mutation among first-line gefitinib, erlotinib and afatinib-treated non-small cell lung cancer patients with activating EGFR mutations.

Lin YT, Chen JS, Liao WY, Ho CC, Hsu CL, Yang CY, Chen KY, Lee JH, Lin ZZ, Shih JY, Yang JC, Yu CJ.

Int J Cancer. 2019 Jun 1;144(11):2887-2896. doi: 10.1002/ijc.32025. Epub 2019 Jan 5.

PMID:
30485437

Supplemental Content

Support Center